Dr. Lal Pathlabs Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 01/02/2024 ,inter alia, to consider and approve the Un-audited (Standalone & Consolidated) Financial Results for the Quarter and Nine Months ended December 31, 2023 and declaration of 2nd interim dividend, if any, on the equity shares of the Company for the Financial Year 2023-24.